![PDF] Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e0dc01ccf28fd86f6fb2d9d5d2827f84c904cfcf/2-Figure1-1.png "PDF] Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules | Semantic Scholar")
PDF] Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules | Semantic Scholar
Biochemical Pharmacology of Pemetrexed
Lung-Tumorzym (LT-Zym) plus Pemetrexed (Alimta) deliver combo punch to terminal non–small cell lung cancer (NSCLC) | Herbalzym
Mechanisms of resistance to pemetrexed in non-small cell lung cancer - Liang - Translational Lung Cancer Research
Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer | Thorax
Figure 2 from Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumors. | Semantic Scholar
Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy | Journal for ImmunoTherapy of Cancer
PPT - First-Line Chemotherapy in Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) PowerPoint Presentation - ID:4546594
Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules | British Journal of Cancer
Associations between TS, TTF-1, FR-α, FPGS, and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Pemetrexed Plus Carboplatin or Gemcitabine Plus Carboplatin as First-Line Chemotherapy - Journal of Thoracic Oncology
Pemetrexed disodium, a novel antifolate with multiple targets - The Lancet Oncology
High pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase
Lung-Tumorzym (LT-Zym) plus Pemetrexed (Alimta) deliver combo punch to terminal non–small cell lung cancer (NSCLC) | Herbalzym
Pemetrexed disodium | Nature Reviews Drug Discovery
Molecules | Free Full-Text | Novel Multitarget Therapies for Lung Cancer and Respiratory Disease | HTML
pemetrexed mechanism of action. | Download Scientific Diagram
Pemetrexed disodium, a novel antifolate with multiple targets - The Lancet Oncology
Frontiers | Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting? | Oncology
Study JMDB - A Randomised Phase III Trial of Cisplatin + Pemetrexed vs - ppt video online download
Synergistic activity of combination therapy with PEGylated pemetrexed and gemcitabine for an effective cancer treatment - ScienceDirect
PPT - Mode of Action PowerPoint Presentation, free download - ID:3629643
PDF) The Role of Pemetrexed in Advanced Non Small-Cell Lung Cancer: Special Focus on Pharmacology and Mechanism of Action
Correlation of genetic polymorphisms with clinical outcomes in pemetrexed-treated advanced lung adenocarcinoma patients | Pharmacogenomics
Pemetrexed in first-line treatment of non-small cell lung cancer - ScienceDirect
Mechanisms, Management and Prevention of Pemetrexed-Related Toxicity | SpringerLink
